The expression level of ARF and p53 in AML patients, and their relation to patients' outcome

Abstract Background Acute myeloid leukemia (AML) is a cancer of hematopoietic progenitors characterized by gene mutations. The most popular deregulations are mutation and altered expression in the p53 gene, which is considered the guardian of the genome. Its activity is controlled by regulatory gene...

Full description

Bibliographic Details
Main Authors: Reem Nabil, Samar S. Elshazly, Naglaa M. Hassan, Hend A. Nooh
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:https://doi.org/10.1186/s43042-023-00410-4